Trial intelligence / Profile preview

Corticosteroids in patients with severe alcoholic hepatitis with early spontaneous improvement

2016-005136-16Phase 2Completed

Sponsor
Erasmus Hospital
Start
Apr 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of methylprednisolone in alcoholic hepatitis (AH), sponsored by Erasmus Hospital. Started Apr 2017; status: completed.

02

Drugs

methylprednisolone
03

Conditions

alcoholic hepatitis (AH)

Beyond the preview

Go deeper on 2016-005136-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-005136-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call